Neuropilin-1 in acute myeloid leukemia: Expression and role in proliferation and migration of leukemia cells

Leukemia and Lymphoma

Volumn 49, Issue 2, 2008, Pages 331-338

  Lu, Lin ^a   Zhang, Lei ^a   Xiao, Zhijian ^a   Lu, Shihong ^a   Yang, Renchi ^a   Han, Zhong Chao ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Acute myeloid leukemia cells; Expression; Migration; Neuropilin 1; Proliferation

Indexed keywords

MESSENGER RNA; NEUROPILIN 1; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOCHEMISTRY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MITOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CHILD; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEUROPILIN-1; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38849094477     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701809149     Document Type: Article

References (27)

1. He, Z. and Tessier-Lavigne, M. (1997) Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell, 90, pp. 739-751.
2. Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y. T., Giger, R. J. and Ginty, D. D. (1997) Neuropilin is a semaphorin III receptor. Cell, 90, pp. 753-762.
3. Kawakami, A., Kitsukawa, T., Takagi, S. and Fujisawa, H. (1996) Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol, 29, pp. 1-17.
4. Takahashi, T., Fournier, A., Nakamura, F., Wang, L. H., Murakami, Y. and Kalb, R. G. (1999) Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell, 99, pp. 59-69.
5. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell, 92, pp. 735-745.
6. Li, M., Yang, H., Chai, H., Fisher, W. E., Wang, X. and Brunicardi, F. C. (2004) Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer, 101, pp. 2341-2350.
7. Kawakami, T., Tokunaga, T., Hatanaka, H., Kijima, H., Yamazaki, H. and Abe, Y. (2002) Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer, 95, pp. 2196-2201.
8. Hansel, D. E., Wilentz, R. E., Yeo, C. J., Schulick, R. D., Montgomery, E. and Maitra, A. (2004) Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol, 28, pp. 347-356.
9. Latil, A., Bieche, I., Pesche, S., Valeri, A., Fournier, G. and Cussenot, O. (2000) VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer, 89, pp. 167-171.
10. Chen, H., Chedotal, A., He, Z., Goodman, C. S. and Tessier-Lavigne, M. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphores Sema E and Sema IV but not Sema III. Neuron, 19, pp. 547-559.
11. Bachelder, R. E., Crago, A., Chung, J. C., Wendt, M. A., Shaw, L. M. and Robinson, G. (2001) Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res, 61, pp. 5736-5740.
12. Schuch, G., Machluf, M., Bartsch, G., Nomi, M., Richard, H. and Atala, A. (2002) In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood, 100, pp. 4622-4628.
13. Kreuter, M., Woelke, K., Bieker, R., Schliemann, C., Steins, M. and Buechner, T. (2006) Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia, 20, pp. 1950-1954.
14. Fiedler, W., Graeven, U., Ergun, S., Verago, S., Kilic, N. and Stockschlader, M. (1997) Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood, 89, pp. 1870-1875.
15. Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M. and Lane, W. (2000) Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest, 106, pp. 511-521.
16. Santos, S. and Dias, S. (2004) Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood, 103, pp. 3883-3889.
17. Parikh, A. A., Fan, F., Liu, W. B., Ahmad, S. A., Stoeltzing, O. and Reinmuth, N. (2004) Neuropilin-1 in human colon cancer: Expression, regulation, and role in induction of angiogenesis. Am J Pathol, 164, pp. 2139-2151.
18. Parikh, A. A., Liu, W. B., Fan, F., Stoeltzing, O., Reinmuth, N. and Bruns, C. J. (2003) Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Cancer, 98, pp. 720-729.
19. Murga, M., Fernandes-Capetillo, O. and Tosato, G. (2005) Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood, 105, pp. 1992-1995.
20. Gray, M. J., Wey, J. S., Belcheva, A., McCarty, M. F., Trevino, J. G. and Evans, D. B. (2005) Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Res, 65, pp. 3664-3670.
21. Bachelder, R. E., Lipscomb, E. A., Lin, X., Wendt, M. A., Chadborn, N. H. and Eickholt, B. J. (2003) Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res, 63, pp. 5230-5233.
22. Miao, H. Q., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A. and Klagsbrun, M. (1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol, 146, pp. 233-242.
23. List, A. F. (2001) Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. Oncologist, 6, pp. 24-31.
24. Bellamy, W. T., Richter, L., Sirjani, D., Roxas, C., Glinsmann-Gibson, B. and Frutiger, Y. (2001) Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood, 97, pp. 1427-1434.
25. Bonsi, L., Pierdomenico, L., Biscardi, M., Marchionni, C., Gavazzi, S. and Fossati, V. (2005) Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: Effect on proliferation and signaling pathway. Int J Immunopathol Pharmacol, 18, pp. 445-455.
26. Miao, H. Q., Lee, P., Lin, H., Soker, S. and Klagsbrun, M. (2000) Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J, 14, pp. 2532-2539.
27. Pan, Q., Changthery, Y., Liang, W. C., Stawicki, S., Mak, J. and Rathore, N. (2007) Blocking Neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer cell, 11, pp. 53-67.